CASE REPORT   

Gazzetta Medica Italiana - Archivio per le Scienze Mediche 2020 April;179(4):296-9

DOI: 10.23736/S0393-3660.19.04153-6

Copyright © 2019 EDIZIONI MINERVA MEDICA

lingua: Inglese

Transcatheter aortic valve implantation for patients with low left ventricular ejection fraction under prophylactic use of veno-arterial extracorporeal membrane oxygenation

Kenji TANINOBU ¹, Mizuki MIURA ² ✉, Shinichi SHIRAI ², Masaomi HAYASHI ², Masahiro ISHIBASHI ¹, Hiroshi TAKIGUCHI ², Shinya ITO ², Mariko YANO ², Tomohiro KAWAGUCHI ², Takashi MORINAGA ², Akihiro ISOTANI ², Shinichi KAKUMOTO ³, Katsuhiro SEO ³, Yoshio ARAI ⁴, Genichi SAKAGUCHI ⁴, Kenji ANDO ²

¹ Department of Clinical Engineering, Kokura Memorial Hospital, Kitakyushu, Japan; ² Department of Cardiology, Kokura Memorial Hospital, Kitakyushu, Japan; ³ Department of Anesthesiology, Kokura Memorial Hospital, Kitakyushu, Japan; ⁴ Department of Cardiovascular Surgery, Kokura Memorial Hospital, Kitakyushu, Japan

Transcatheter aortic valve implantation (TAVI) has been established as a treatment of choice for patients with severe symptomatic aortic stenosis who are considered ineligible or at high risk for surgical aortic valve replacement, so the number of TAVI procedures for patients with prohibitive risk has rapidly increased in the super-aging society. We described two cases of TAVI for patients with low left ventricular ejection fraction under prophylactic use of veno-arterial extracorporeal membrane oxygenation and percutaneous removal using Perclose ProGlide (Abbott Vascular, Clonmel, Ireland).

KEY WORDS: Transcatheter aortic valve replacement; Aortic valve stenosis; Stroke volume; Extracorporeal membrane oxygenation